Document Type
Amicus Brief
Publication Date
7-14-2026
Case Name
Parent AA, et al., v. United States Department of Justice
Abstract
INTRODUCTION: Physicians’ use of their judgment and expertise to prescribe drugs and devices for purposes other than those approved by the Food and Drug Administration (“FDA”)—colloquially known as off-label use—is an indispensable feature of modern medicine. The FDA approves drugs as “safe and effective for specific indications.” Christopher M. Wittich, Christopher M. Burkle & William L. Lanier, Ten Common Questions (and Their Answers) About OffLabel Drug Use, 87 Mayo Clinic Procs. 982, 982 (2012). Federal law then generally leaves prescribing decisions, including off-label use of FDA-approved drugs and devices for a patient’s particular indication, to physicians acting under state law and professional standards
Recommended Citation
Zacharias, Rachel L.; Bakhet, Zeinab; Costello, Kevin; and Manian, Maya, "Brief of Public Health and Health Law Scholars as Amici Curiae Urging Affirmance in Support of Plaintiffs-Appellees" (2026). Amicus Briefs & Court Filings. 72.
https://digitalcommons.wcl.american.edu/pub_disc_briefs/72
Included in
Bioethics and Medical Ethics Commons, Civil Rights and Discrimination Commons, Food and Drug Law Commons, Health Law and Policy Commons, Juvenile Law Commons, Law and Gender Commons, Law and Politics Commons, Other Public Health Commons, Privacy Law Commons, Public Interest Commons